A strategy for the development of two clinically active cisplatin analogs: CBDCA and CHIP.
about
Toxicological and tumoricidal evaluations of a new platinum complex, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato+ ++)platinum( II) monohydrate, in rats.Modulation of cis-diamminedichloroplatinum(II) resistance: a review.A new anticancer platinum compound, (-)-(R)-2-aminomethyl-pyrrolidine(1,1-cyclobutanedicarboxylato) platinum(II): DNA interstrand crosslinking, repair and lethal effects in normal human, Fanconi's anaemia and xeroderma pigmentosum cells.
P2860
A strategy for the development of two clinically active cisplatin analogs: CBDCA and CHIP.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
A strategy for the development ...... latin analogs: CBDCA and CHIP.
@en
A strategy for the development ...... latin analogs: CBDCA and CHIP.
@nl
type
label
A strategy for the development ...... latin analogs: CBDCA and CHIP.
@en
A strategy for the development ...... latin analogs: CBDCA and CHIP.
@nl
prefLabel
A strategy for the development ...... latin analogs: CBDCA and CHIP.
@en
A strategy for the development ...... latin analogs: CBDCA and CHIP.
@nl
P2093
P356
P1476
A strategy for the development ...... latin analogs: CBDCA and CHIP.
@en
P2093
B J Foster
B J Harding
B Leyland-Jones
K Clagett-Carr
L Y Rubinstein
M K Wolpert-DeFilippes
P2888
P304
P356
10.1007/BF00686049
P577
1990-01-01T00:00:00Z